Showing results (431-440 of 472) with videos related to
Sort By:
Pageof 48
Therapeutic Advances in Cardiovascular Disease|October 23, 2010
Exercise improves hemodynamic profiles and increases red blood cell concentrations of purine nucleotides in a rodent modelPollen K F Yeung, Julie Dauphinee, Thera Gouzoules, et al.Therapeutic Advances in Cardiovascular Disease|October 23, 2010
Recent advances in oral anticoagulation for atrial fibrillationMukesh Singh, Sasikanth Adigopula, Pawan Patel, et al.Therapeutic Advances in Cardiovascular Disease|March 15, 2013
Testosterone reduces vascular relaxation by altering cyclic adenosine monophosphate pathway and potassium channel activation in male Sprague Dawley rats fed a high-salt dietAhmed K Oloyo, Olusoga A Sofola, Chikodi N Anigbogu, et al.Therapeutic Advances in Cardiovascular Disease|January 19, 2013
Angiotensin II receptor blockade and insulin sensitivity in overweight and obese adults with elevated blood pressureElaina L Marinik, Madlyn I Frisard, Matthew W Hulver, et al.Therapeutic Advances in Cardiovascular Disease|February 8, 2013
Effect of acute exercise on cardiovascular hemodynamic and red blood cell concentrations of purine nucleotides in hypertensive compared with normotensives ratsPollen K F Yeung, Julie Dauphinee, Tanya MarcouxTherapeutic Advances in Cardiovascular Disease|August 13, 2014
A rare cause of cardiogenic shock: variant anginaAysel Akhundova, Murat Sunbul, Mehmet Bozbay, et al.Therapeutic Advances in Cardiovascular Disease|December 15, 2012
Statin therapy and the risk for diabetes among adult women: do the benefits outweigh the risk?Yunsheng Ma, Annie Culver, Jacques Rossouw, et al.Therapeutic Advances in Cardiovascular Disease|August 16, 2013
Management of hypertension with fixed-dose triple-combination treatmentsBenjamin J Epstein, Niren K Shah, Nancy L Borja-HartTherapeutic Advances in Cardiovascular Disease|December 12, 2013
The relationship between serum bilirubin concentration and coronary slow flowMehmet Demir, Canan Demir, Selvi CoşarTherapeutic Advances in Cardiovascular Disease|December 12, 2013
Sevelamer revisited: pleiotropic effects on endothelial and cardiovascular risk factors in chronic kidney disease and end-stage renal diseaseAnjay RastogiPageof 48